Sangamo Therapeutics Inc (SGMO) Stock Price, Quote, News & History | Benzinga

SPY769.86+0.03%QQQ749.55−0.00%BTC/USD85,360.52+0.73%DIA511.70+0.12%GLD380.52+0.10%TLT77.53+0.06%

Sangamo Therapeutics Inc (SGMO) Stock Price, Quote, News & History

SGMOOTC

Trade with Public

Trade with Public

$0.0777

-0.0999-56.25%

Last update: Jun 23, 9:29 AM

$0.0777

-0.0999-56.25%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

0.06 - 0.76

Market Cap

-

P/E Ratio

-

Dividend Yield

-

Exchange

OTC

RSI

-

Short Interest

-

Days to Cover

4.13

Recent Sangamo Therapeutics Inc News

Sangamo Bankruptcy Puts Gene Therapy Platforms In Play, Eli Lilly And Astellas Circle

Sangamo files for Chapter 11 as Eli Lilly and Astellas step in to buy its valuable gene therapy and genome-editing assets.

Vandana Singh

Deal Dispatch: Carlyle Buys Chung Ho Group, Second Nature Brands Acquires Tillamook Country Smoker, GoHealth Bankruptcy

SGMO explores strategic alternatives, ZOOZ considers complementing bitcoin strategy, Arcline acquires Continental, Mill Point buys Total Safety, Carlyle acquires Chung Ho Group.

Caroline Ryan

Crude Oil Jumps 5%; Automatic Data Processing Posts Upbeat Earnings

Avi Kapoor

Dow Falls 100 Points; Brinker Earnings Beat Estimates

US stocks lower, Dow falls 100 points. Energy shares up 1%, communication services down 0.7%. Brinker beats earnings, raises guidance. SAGT up 79%.

Avi Kapoor

Why Virgin Galactic Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Virgin Galactic reported Q4 revenue of $312,000, missing estimates, but beat EPS expectations. Its second SpaceShip is expected to enter service soon, causing a 6% jump in pre-market trading. Other gainers included ARTL, AFBI, and BIRD, while PEPG and PHR were among the losers.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

2.3

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell